TTP Labtech Revenues up 43%
News Jun 23, 2014
Most of this growth is based on the strength of TTP Labtech’s core products in the areas of cell imaging, liquid handling and sample management. In particular mirrorball® and comPOUND® saw an accelerated growth of over 300%.
“We have a team of passionate, talented and dedicated individuals behind each product and a collaborative relationship with our customers – something that differentiates us from other technology-based companies”, remarked Dr Jas Sanghera, managing director at TTP Labtech.
A focus on global distribution has led to 24% of product sales outside of the US and Europe, with a significant proportion of this in Asia. TTP Labtech is now in a strong position to continue growing the business. Dr Sanghera’s strategy to maintain the focus on product quality, even in a challenging economic environment, has proved to be successful.
Continued success also requires maintaining an innovative culture and a willingness to adapt to market changes. The current trend in assay development is a move towards greater levels of both accuracy and precision, while making use of smaller volumes at an increased throughput – a challenge which can only be assured by automated instrumentation. Many of TTP Labtech’s products, in particular the mosquito range, are well positioned to rise to this challenge and provide real value to customers in that field.
Dr Sanghera continued, “We predict strong growth for the next year from our most recently launched products (dragonfly® and arktic®). In addition we have opened a new online store for consumables that we expect will make a significant contribution to the revenue next year. Innovation, which is so important for the company, is driven by our strong focus on our customers and we will continue to develop these relationships in the future”.
LifeArc Becomes Technology Transfer Partner to London School of Hygiene & Tropical MedicineNews
LifeArc, the medical research charity, has partnered with London School of Hygiene & Tropical Medicine to provide a range of services in technology transfers.READ MORE
Acquisition Sees Agilent Gain Powerful NGS IP PortfolioNews
Agilent Technologies announces its acquisition of the molecular and sample barcoding portfolios of Population Genetics Technologies.READ MORE
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Comments | 0 ADD COMMENT
International Conference on Genomics and Pharmacogenomics
Jul 18 - Jul 19, 2018
International Conference and Exhibition on Nanomedicine and Nanotechnology
Nov 23 - Nov 24, 2017